The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Drug Delivery Systems Market Research Report 2025
Synopsis
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
The global Injectable Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Systems.
Report Scope
The Injectable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik
Segment by Type
Pre-filled Syringes
Auto-injectors (Syringe and Cartridge Based)
Pen Injectors
Others
Segment by Application
Hospitals & Clinics
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
The global Injectable Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Systems.
Report Scope
The Injectable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik
Segment by Type
Pre-filled Syringes
Auto-injectors (Syringe and Cartridge Based)
Pen Injectors
Others
Segment by Application
Hospitals & Clinics
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injectable Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Injectable Drug Delivery Systems
1.2 Injectable Drug Delivery Systems Segment by Type
1.2.1 Global Injectable Drug Delivery Systems Market Value Comparison by Type (2024-2030)
1.2.2 Pre-filled Syringes
1.2.3 Auto-injectors (Syringe and Cartridge Based)
1.2.4 Pen Injectors
1.2.5 Others
1.3 Injectable Drug Delivery Systems Segment by Application
1.3.1 Global Injectable Drug Delivery Systems Market Value by Application: (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Home Care
1.3.4 Others
1.4 Global Injectable Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery Systems Revenue 2019-2030
1.4.2 Global Injectable Drug Delivery Systems Sales 2019-2030
1.4.3 Global Injectable Drug Delivery Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Injectable Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Drug Delivery Systems Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Drug Delivery Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery Systems, Product Type & Application
2.7 Injectable Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Injectable Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Injectable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Injectable Drug Delivery Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Drug Delivery Systems Global Injectable Drug Delivery Systems Sales by Region: 2019-2030
3.2.1 Global Injectable Drug Delivery Systems Sales by Region: 2019-2024
3.2.2 Global Injectable Drug Delivery Systems Sales by Region: 2025-2030
3.3 Global Injectable Drug Delivery Systems Global Injectable Drug Delivery Systems Revenue by Region: 2019-2030
3.3.1 Global Injectable Drug Delivery Systems Revenue by Region: 2019-2024
3.3.2 Global Injectable Drug Delivery Systems Revenue by Region: 2025-2030
3.4 North America Injectable Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Drug Delivery Systems Sales by Country (2019-2030)
3.4.3 North America Injectable Drug Delivery Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Drug Delivery Systems Sales by Country (2019-2030)
3.5.3 Europe Injectable Drug Delivery Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Drug Delivery Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Drug Delivery Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Drug Delivery Systems Sales by Country (2019-2030)
3.7.3 Latin America Injectable Drug Delivery Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Drug Delivery Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Drug Delivery Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injectable Drug Delivery Systems Sales by Type (2019-2030)
4.1.1 Global Injectable Drug Delivery Systems Sales by Type (2019-2024)
4.1.2 Global Injectable Drug Delivery Systems Sales by Type (2025-2030)
4.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Type (2019-2030)
4.2 Global Injectable Drug Delivery Systems Revenue by Type (2019-2030)
4.2.1 Global Injectable Drug Delivery Systems Revenue by Type (2019-2024)
4.2.2 Global Injectable Drug Delivery Systems Revenue by Type (2025-2030)
4.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Drug Delivery Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Drug Delivery Systems Sales by Application (2019-2030)
5.1.1 Global Injectable Drug Delivery Systems Sales by Application (2019-2024)
5.1.2 Global Injectable Drug Delivery Systems Sales by Application (2025-2030)
5.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Application (2019-2030)
5.2 Global Injectable Drug Delivery Systems Revenue by Application (2019-2030)
5.2.1 Global Injectable Drug Delivery Systems Revenue by Application (2019-2024)
5.2.2 Global Injectable Drug Delivery Systems Revenue by Application (2025-2030)
5.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Drug Delivery Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Injectable Drug Delivery Systems Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Corporation Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Becton, Dickinson Injectable Drug Delivery Systems Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Corporation Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gerresheimer Injectable Drug Delivery Systems Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Injectable Drug Delivery Systems Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Schott
6.5.1 Schott Corporation Information
6.5.2 Schott Description and Business Overview
6.5.3 Schott Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Schott Injectable Drug Delivery Systems Product Portfolio
6.5.5 Schott Recent Developments/Updates
6.6 ELI Lilly
6.6.1 ELI Lilly Corporation Information
6.6.2 ELI Lilly Description and Business Overview
6.6.3 ELI Lilly Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ELI Lilly Injectable Drug Delivery Systems Product Portfolio
6.6.5 ELI Lilly Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Injectable Drug Delivery Systems Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Terumo Injectable Drug Delivery Systems Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Injectable Drug Delivery Systems Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Novo Nordik
6.10.1 Novo Nordik Corporation Information
6.10.2 Novo Nordik Description and Business Overview
6.10.3 Novo Nordik Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novo Nordik Injectable Drug Delivery Systems Product Portfolio
6.10.5 Novo Nordik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery Systems Industry Chain Analysis
7.2 Injectable Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery Systems Production Mode & Process
7.4 Injectable Drug Delivery Systems Sales and Marketing
7.4.1 Injectable Drug Delivery Systems Sales Channels
7.4.2 Injectable Drug Delivery Systems Distributors
7.5 Injectable Drug Delivery Systems Customers
8 Injectable Drug Delivery Systems Market Dynamics
8.1 Injectable Drug Delivery Systems Industry Trends
8.2 Injectable Drug Delivery Systems Market Drivers
8.3 Injectable Drug Delivery Systems Market Challenges
8.4 Injectable Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Injectable Drug Delivery Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Injectable Drug Delivery Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Injectable Drug Delivery Systems Market Competitive Situation by Manufacturers in 2023
Table 4. Global Injectable Drug Delivery Systems Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Injectable Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Injectable Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Injectable Drug Delivery Systems Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Injectable Drug Delivery Systems Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Injectable Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Injectable Drug Delivery Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injectable Drug Delivery Systems, Product Type & Application
Table 12. Global Key Manufacturers of Injectable Drug Delivery Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drug Delivery Systems as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Injectable Drug Delivery Systems Sales by Region (2019-2024) & (K Units)
Table 18. Global Injectable Drug Delivery Systems Sales Market Share by Region (2019-2024)
Table 19. Global Injectable Drug Delivery Systems Sales by Region (2025-2030) & (K Units)
Table 20. Global Injectable Drug Delivery Systems Sales Market Share by Region (2025-2030)
Table 21. Global Injectable Drug Delivery Systems Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Injectable Drug Delivery Systems Revenue Market Share by Region (2019-2024)
Table 23. Global Injectable Drug Delivery Systems Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Injectable Drug Delivery Systems Revenue Market Share by Region (2025-2030)
Table 25. North America Injectable Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Injectable Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 27. North America Injectable Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 28. North America Injectable Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Injectable Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Injectable Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Injectable Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 32. Europe Injectable Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 33. Europe Injectable Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Injectable Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Injectable Drug Delivery Systems Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Injectable Drug Delivery Systems Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Injectable Drug Delivery Systems Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Injectable Drug Delivery Systems Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Injectable Drug Delivery Systems Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Injectable Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Injectable Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Injectable Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Injectable Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injectable Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injectable Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Injectable Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Injectable Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Injectable Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Injectable Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Injectable Drug Delivery Systems Sales (K Units) by Type (2019-2024)
Table 51. Global Injectable Drug Delivery Systems Sales (K Units) by Type (2025-2030)
Table 52. Global Injectable Drug Delivery Systems Sales Market Share by Type (2019-2024)
Table 53. Global Injectable Drug Delivery Systems Sales Market Share by Type (2025-2030)
Table 54. Global Injectable Drug Delivery Systems Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Injectable Drug Delivery Systems Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Injectable Drug Delivery Systems Revenue Market Share by Type (2019-2024)
Table 57. Global Injectable Drug Delivery Systems Revenue Market Share by Type (2025-2030)
Table 58. Global Injectable Drug Delivery Systems Price (US$/Unit) by Type (2019-2024)
Table 59. Global Injectable Drug Delivery Systems Price (US$/Unit) by Type (2025-2030)
Table 60. Global Injectable Drug Delivery Systems Sales (K Units) by Application (2019-2024)
Table 61. Global Injectable Drug Delivery Systems Sales (K Units) by Application (2025-2030)
Table 62. Global Injectable Drug Delivery Systems Sales Market Share by Application (2019-2024)
Table 63. Global Injectable Drug Delivery Systems Sales Market Share by Application (2025-2030)
Table 64. Global Injectable Drug Delivery Systems Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Injectable Drug Delivery Systems Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Injectable Drug Delivery Systems Revenue Market Share by Application (2019-2024)
Table 67. Global Injectable Drug Delivery Systems Revenue Market Share by Application (2025-2030)
Table 68. Global Injectable Drug Delivery Systems Price (US$/Unit) by Application (2019-2024)
Table 69. Global Injectable Drug Delivery Systems Price (US$/Unit) by Application (2025-2030)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Baxter Injectable Drug Delivery Systems Product
Table 74. Baxter Recent Developments/Updates
Table 75. Becton, Dickinson Corporation Information
Table 76. Becton, Dickinson Description and Business Overview
Table 77. Becton, Dickinson Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Becton, Dickinson Injectable Drug Delivery Systems Product
Table 79. Becton, Dickinson Recent Developments/Updates
Table 80. Gerresheimer Corporation Information
Table 81. Gerresheimer Description and Business Overview
Table 82. Gerresheimer Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Gerresheimer Injectable Drug Delivery Systems Product
Table 84. Gerresheimer Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Injectable Drug Delivery Systems Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Schott Corporation Information
Table 91. Schott Description and Business Overview
Table 92. Schott Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Schott Injectable Drug Delivery Systems Product
Table 94. Schott Recent Developments/Updates
Table 95. ELI Lilly Corporation Information
Table 96. ELI Lilly Description and Business Overview
Table 97. ELI Lilly Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. ELI Lilly Injectable Drug Delivery Systems Product
Table 99. ELI Lilly Recent Developments/Updates
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novartis Injectable Drug Delivery Systems Product
Table 104. Novartis Recent Developments/Updates
Table 105. Terumo Corporation Information
Table 106. Terumo Description and Business Overview
Table 107. Terumo Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Terumo Injectable Drug Delivery Systems Product
Table 109. Terumo Recent Developments/Updates
Table 110. Teva Pharmaceutical Corporation Information
Table 111. Teva Pharmaceutical Description and Business Overview
Table 112. Teva Pharmaceutical Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Teva Pharmaceutical Injectable Drug Delivery Systems Product
Table 114. Teva Pharmaceutical Recent Developments/Updates
Table 115. Novo Nordik Corporation Information
Table 116. Novo Nordik Description and Business Overview
Table 117. Novo Nordik Injectable Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novo Nordik Injectable Drug Delivery Systems Product
Table 119. Novo Nordik Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Injectable Drug Delivery Systems Distributors List
Table 123. Injectable Drug Delivery Systems Customers List
Table 124. Injectable Drug Delivery Systems Market Trends
Table 125. Injectable Drug Delivery Systems Market Drivers
Table 126. Injectable Drug Delivery Systems Market Challenges
Table 127. Injectable Drug Delivery Systems Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injectable Drug Delivery Systems
Figure 2. Global Injectable Drug Delivery Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Injectable Drug Delivery Systems Market Share by Type in 2023 & 2030
Figure 4. Pre-filled Syringes Product Picture
Figure 5. Auto-injectors (Syringe and Cartridge Based) Product Picture
Figure 6. Pen Injectors Product Picture
Figure 7. Others Product Picture
Figure 8. Global Injectable Drug Delivery Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Injectable Drug Delivery Systems Market Share by Application in 2023 & 2030
Figure 10. Hospitals & Clinics
Figure 11. Home Care
Figure 12. Others
Figure 13. Global Injectable Drug Delivery Systems Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Injectable Drug Delivery Systems Market Size (2019-2030) & (US$ Million)
Figure 15. Global Injectable Drug Delivery Systems Sales (2019-2030) & (K Units)
Figure 16. Global Injectable Drug Delivery Systems Average Price (US$/Unit) & (2019-2030)
Figure 17. Injectable Drug Delivery Systems Report Years Considered
Figure 18. Injectable Drug Delivery Systems Sales Share by Manufacturers in 2023
Figure 19. Global Injectable Drug Delivery Systems Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Injectable Drug Delivery Systems Players: Market Share by Revenue in 2023
Figure 21. Injectable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Injectable Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Injectable Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 24. North America Injectable Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Injectable Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 28. Europe Injectable Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 29. Germany Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Injectable Drug Delivery Systems Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Injectable Drug Delivery Systems Revenue Market Share by Region (2019-2030)
Figure 36. China Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Injectable Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 47. Latin America Injectable Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Injectable Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Injectable Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Injectable Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Injectable Drug Delivery Systems by Type (2019-2030)
Figure 57. Global Revenue Market Share of Injectable Drug Delivery Systems by Type (2019-2030)
Figure 58. Global Injectable Drug Delivery Systems Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Injectable Drug Delivery Systems by Application (2019-2030)
Figure 60. Global Revenue Market Share of Injectable Drug Delivery Systems by Application (2019-2030)
Figure 61. Global Injectable Drug Delivery Systems Price (US$/Unit) by Application (2019-2030)
Figure 62. Injectable Drug Delivery Systems Value Chain
Figure 63. Injectable Drug Delivery Systems Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
